QA: ATAI Life Sciences N.V. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001840904_2023_ATAI_Life_Sciences_N_V.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001840904, ATAI Life Sciences N.V.

  xvar xval
0 AssetsCurrent 287,145,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 928,000
3 remainder_Assets 17,368,000
4 LiabilitiesCurrent 19,897,000
5 LiabilitiesNoncurrent 3,708,000
6 remainder_Liabilities 16,070,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 70,350,000
9 ResearchAndDevelopmentExpense 74,313,000
10 remainder_Expenses 6,586,000
11 remainder_Revenues 233,000
12 remainder_NetIncome -6,401,000
13 remainder_ComprehensiveNetIncome -8,384,000
  yvar yval
0 Assets 305,441,000
1 Liabilities 39,675,000
2 Expenses 151,249,000
3 Revenues 233,000
4 StockholdersEquity 265,766,000
5 NetIncome -157,417,000
6 ComprehensiveNetIncome -161,609,000
7 BaseVar 255,691,500
8 EconomicCapitalRatio 1.71

Edgar->Model Mapping

Feature Distribution

Change over Time